Project Number GH-2013373 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2016 View Full Project Details for 2nd Annual Goodes Prize for Excellence in Alzheimer's Drug Discovery: Catalyzing p38aMAPKI Drug Candidate, MW150, Into the Clinic Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) f. Inflammation Researcher and Organization Principal Investigator Watterson, D. Principal Investigator First Name D. Principal Investigator Last Name Watterson Awardee Organization Neurokine Therapeutics Awardee State New York, N.Y. Contact PI Country United States Project Detail Funding Opportunity Announcement No RFP FY Overall Cost $150,000 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States
